Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EXEL
EXEL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EXEL News
Three Biotech Companies Worth Watching
3d ago
NASDAQ.COM
Three Biotech Stocks Worth Watching
3d ago
Fool
Exelixis Market Trends Analysis
Apr 01 2026
Fool
Exelixis Investment Insights from Motley Fool
Apr 01 2026
NASDAQ.COM
High-Quality Healthcare Stocks Under $50
Mar 18 2026
Fool
Amazon Launches Ultra-Fast Delivery Service
Mar 17 2026
Fool
Exelixis Aims to Expand Beyond Cabozantinib Franchise
Feb 28 2026
NASDAQ.COM
Exelixis Aims to Become a Top Oncology Player with Expanding Pipeline
Feb 28 2026
Fool
Global Oncology Market Expected to Reach $748.17 Billion
Feb 24 2026
PRnewswire
Global Oncology Market Expected to Reach $748.17 Billion
Feb 24 2026
Newsfilter
Exelixis Growth Potential Analysis
Feb 20 2026
Fool
Exelixis Posts Strong Earnings—Could New Highs Be on the Horizon?
Feb 12 2026
Marketbeat
Exelixis Q4 2025 Earnings Call Highlights
Feb 11 2026
seekingalpha
EXELIXIS Q4 ADJUSTED EPS REACHES USD 0.94, BEATING IBES ESTIMATE OF USD 0.79
Feb 10 2026
moomoo
Exelixis Q4 Earnings Beat Expectations with Strong Guidance
Feb 10 2026
seekingalpha
Exelixis Set to Announce Q4 Earnings on February 10th
Feb 09 2026
seekingalpha
Show More News
